spierbiopt

Spierbiopt, or muscle biopsy, is a diagnostic procedure in which a small sample of skeletal muscle is removed for laboratory examination. The aim is to study muscle fiber structure, enzyme activity, and metabolic features to help diagnose neuromuscular disorders.

Most procedures are performed percutaneously under local anesthesia. A needle biopsy (or open biopsy) may be used. The sample is typically taken from a clinically affected muscle such as vastus lateralis or deltoid. Portions are processed for histology, biochemistry, and, if needed, genetic testing.

Indications include suspected inflammatory myopathies, muscular dystrophy, congenital myopathies, metabolic disorders, and suspected mitochondrial disease. Biopsy findings can refine diagnosis, guide treatment decisions, and sometimes reveal unexpected conditions.

Processing involves histology, enzyme histochemistry, and immunohistochemistry. In selected cases, electron microscopy may be used. Pathologists assess fiber size variation, necrosis, inflammation, mitochondrial proliferation, and connective tissue changes; results are interpreted alongside clinical information and imaging.

Risks are generally low and include pain, bleeding, infection, hematoma, and nerve injury. Most patients recover quickly; activity may be limited for a short period after the procedure.

Non-invasive imaging such as MRI can show muscle involvement but cannot replace biopsy for definitive diagnosis. Genetic testing using blood or tissue DNA may confirm inherited conditions and, when needed, targeted biopsy guided by imaging can improve diagnostic yield.